Notes
see Reactions 1545 p2; 803117561
Reference
FDA. Hepatitis C Treatments Containing Sofosbuvir in Combination With Another Direct Acting Antiviral Drug: Drug Safety Communication - Serious Slowing of Heart Rate When Used With Antiarrhythmic Drug Amiodarone. Internet Document : 24 Mar 2015. Available from: URL: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm439662.htm
Rights and permissions
About this article
Cite this article
Amiodarone + sofosbuvir interaction: FDA warns of bradycardia. Reactions Weekly 1545, 3 (2015). https://doi.org/10.1007/s40278-015-9094-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-9094-2